Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 August 2021 | Story Ruan Bruwer
Louzanne Coetzee at the Paralympics in Tokyo with her two guides, Claus Kempen (left) and Estean Badenhorst. She is one of 34 members in Team South Africa.

For some athletes, the postponement of the Paralympics was a big frustration, but for Louzanne Coetzee it was a ‘blessing in disguise’.

According to the former University of the Free State (UFS) student and current Residence Head of Akasia on the UFS Bloemfontein Campus, she was more than happy to get another 12 months to prepare herself to the very best of her ability. She will be in action at the Tokyo Paralympics in the 1 500 m on Sunday (29 August 2021) and Monday (30 August). On 5 September, she will tackle the marathon. It is her second Paralympics. 

“This is the most exited I have ever been for an event. It has been so long since I was able to compete on a high level. I think it is a blessing in disguise. It allowed me more time to prepare. I’m in a great state and I cannot wait,” she said.

In the 1 500 m, Coetzee will be guided by Estean Badenhorst. In the marathon she will run next to Claus Kempen, with whom she has completed a couple of marathons before.
“They are both very experienced and I’m fortunate to have such a great team with me. When you are running an event like the 1 500 m, you need to fully trust your guide with his decision making.”

“The main focus is the track item. I won’t put too much pressure on myself in the marathon. The prime goal is to gain experience in the longer distance, because that is where I’ll be shifting in the future,” she explained.

The South African 1 500 m record holder in the T11 classification (totally blind) clocked a personal best time of 4:51.65 in 2019. She is the world record holder in the 5 000 m; however, the item does not feature on the Paralympic programme. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept